BEAM
Price
$23.61
Change
-$0.12 (-0.51%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
2.4B
47 days until earnings call
BHVN
Price
$13.73
Change
-$0.43 (-3.04%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
1.5B
55 days until earnings call
Interact to see
Advertisement

BEAM vs BHVN

Header iconBEAM vs BHVN Comparison
Open Charts BEAM vs BHVNBanner chart's image
Beam Therapeutics
Price$23.61
Change-$0.12 (-0.51%)
Volume$23.31K
Capitalization2.4B
Biohaven
Price$13.73
Change-$0.43 (-3.04%)
Volume$7.12K
Capitalization1.5B
BEAM vs BHVN Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. BHVN commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and BHVN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (BEAM: $23.73 vs. BHVN: $14.16)
Brand notoriety: BEAM and BHVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 68% vs. BHVN: 138%
Market capitalization -- BEAM: $2.4B vs. BHVN: $1.5B
BEAM [@Biotechnology] is valued at $2.4B. BHVN’s [@Biotechnology] market capitalization is $1.5B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileBHVN’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • BHVN’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than BHVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 6 TA indicator(s) are bullish while BHVN’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 6 bullish, 4 bearish.
  • BHVN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than BHVN.

Price Growth

BEAM (@Biotechnology) experienced а +3.58% price change this week, while BHVN (@Biotechnology) price change was +4.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was +10.70%, and the average quarterly price growth was +54.52%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

BHVN is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.4B) has a higher market cap than BHVN($1.5B). BEAM YTD gains are higher at: -4.315 vs. BHVN (-62.088). BEAM has higher annual earnings (EBITDA): -414.33M vs. BHVN (-792.68M). BEAM has more cash in the bank: 1.15B vs. BHVN (405M). BEAM has less debt than BHVN: BEAM (155M) vs BHVN (292M). BEAM has higher revenues than BHVN: BEAM (60.3M) vs BHVN (0).
BEAMBHVNBEAM / BHVN
Capitalization2.4B1.5B160%
EBITDA-414.33M-792.68M52%
Gain YTD-4.315-62.0887%
P/E RatioN/AN/A-
Revenue60.3M0-
Total Cash1.15B405M284%
Total Debt155M292M53%
FUNDAMENTALS RATINGS
BHVN: Fundamental Ratings
BHVN
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMBHVN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
70%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 7 days ago
74%
Declines
ODDS (%)
Bearish Trend 23 days ago
85%
Bearish Trend 9 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ILVBX10.900.01
+0.09%
Columbia Integrated Large Cap Val A
WIEFX16.23-0.02
-0.12%
Boston Trust Walden International Eq
MIGFX45.03-0.25
-0.55%
MFS Massachusetts Inv Gr Stk A
NBSSX36.19-0.23
-0.63%
Neuberger Berman Focus Investor
MTCAX70.43-0.82
-1.15%
MFS Technology A

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-2.79%
CRSP - BEAM
67%
Closely correlated
-2.16%
NTLA - BEAM
63%
Loosely correlated
-1.04%
RXRX - BEAM
61%
Loosely correlated
-3.41%
NRIX - BEAM
56%
Loosely correlated
-2.25%
SYRE - BEAM
55%
Loosely correlated
+4.77%
More

BHVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BHVN has been loosely correlated with SYRE. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if BHVN jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHVN
1D Price
Change %
BHVN100%
-4.65%
SYRE - BHVN
53%
Loosely correlated
+4.77%
CGON - BHVN
49%
Loosely correlated
-0.92%
CRNX - BHVN
48%
Loosely correlated
+6.35%
BEAM - BHVN
47%
Loosely correlated
-2.79%
ELVN - BHVN
46%
Loosely correlated
-3.66%
More